BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 33911464)

  • 1. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
    Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
    World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
    Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
    de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
    Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
    Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
    World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 on the Intestinal Microbiome.
    Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
    Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
    Bostancıklıoğlu M
    Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.
    Al-Beltagi M; Saeed NK; Bediwy AS; El-Sawaf Y
    World J Gastroenterol; 2021 Apr; 27(16):1716-1727. PubMed ID: 33967552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
    Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
    Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
    Suryana KD; Simadibrata M; Renaldi K
    Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and gastrointestinal system: A brief review.
    Pola A; Murthy KS; Santhekadur PK
    Biomed J; 2021 Jun; 44(3):245-251. PubMed ID: 34130944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory effect on the gastrointestinal system associated with COVID-19.
    Delgado-Gonzalez P; Gonzalez-Villarreal CA; Roacho-Perez JA; Quiroz-Reyes AG; Islas JF; Delgado-Gallegos JL; Arellanos-Soto D; Galan-Huerta KA; Garza-Treviño EN
    World J Gastroenterol; 2021 Jul; 27(26):4160-4171. PubMed ID: 34326616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management.
    Deidda S; Tora L; Firinu D; Del Giacco S; Campagna M; Meloni F; Orrù G; Chessa L; Carta MG; Melis A; Spolverato G; Littera R; Perra A; Onali S; Zorcolo L; Restivo A
    Expert Rev Gastroenterol Hepatol; 2021 Jan; 15(1):41-50. PubMed ID: 32955375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.